yingweiwo

G protein-coupled Bile Acid Receptor

G protein-coupled Bile Acid Receptor

Bile acids serve as the ligand for the plasma membrane-bound G protein-coupled bile acid receptor 1 (GPCR19, TGR5, GPBAR1). Energy homeostasis, bile acid homeostasis, and glucose metabolism are all regulated by GPCR19. GPCR19 uses heterotrimeric G proteins to transmit extracellular signals.

Bile acids have the ability to activate GPCR19, which then triggers the production of cAMP. GPCR19 is a membrane receptor that, in response to ligands, can internalize into the cytoplasm. GPCR19 is crucial for cell signaling pathways like nuclear factor-B (NF-B), extracellular signal-regulated kinases (ERK), and akt (AKT). Potential medications for the treatment of digestive, inflammatory, and metabolic disorders include its agonists. Additionally, GPCR19 promotes the release of the hormone glucagon-like peptide 1 (GLP-1). It has also developed into a desirable therapeutic target for the prevention and/or treatment of obesity, Type II diabetes, and the metabolic syndrome, which are all closely related to obesity.

G protein-coupled Bile Acid Receptor related products

Structure Cat No. Product Name CAS No. Product Description
(4′R)-TGR5 Receptor Agonist 4 V121587 (4′R)-TGR5 Receptor Agonist 4 1872436-55-9 (4′R)-TGR5 Receptor Agonist 4 is the R enantiomer of TGR5 receptor agonist 4.
(7α,24S)-7,24-Dihydroxycholest-4-en-3-one V121668 (7α,24S)-7,24-Dihydroxycholest-4-en-3-one 2260669-16-5 (7α,24S)-7,24-Dihydroxycholest-4-en-3-one is an oxosterol.
2-Bromo-LSD D-Tartrate V124539 2-Bromo-LSD D-Tartrate 2855123-30-5 2-Bromo-LSD D-Tartrate is a partial agonist and competitive partial antagonist of the 5-HT2A receptor that can cross the blood-brain barrier.
3-MPPI V125529 3-MPPI 133399-65-2 3-MPPI is a G protein-coupled receptor (GPCR) ligand with high selectivity for α1-adrenergic receptors. Its Ki value for α1-adrenergic receptors is 0.21 nM, and its Ki value for 5-HT1A receptors is 50 nM.
5-HT7R antagonist 1 V75364 5-HT7R antagonist 1 2759919-13-4 5-HT7R antagonist 1 is a G protein-biased antagonist of 5-HT7R (Ki = 6.5 nM).
5-HT7R antagonist 1 free base V75362 5-HT7R antagonist 1 free base 2337008-64-5 5-HT7R antagonist 1 (free base) is a G protein-biased antagonist of 5-HT7R (Ki = 6.5 nM).
6ECA V127387 6ECA 647011-80-1 6ECA is a selective TGR5 receptor activator with an EC50 value of 3.44 μM.
AP-503 V129213 AP-503 767299-99-0 AP-503 is a selective GPR133/ADGRD1 agonist with an EC50 of 1.21 nM.
CCG258208 hydrochloride (GRK2-IN-1 hydrochloride) V77161 CCG258208 hydrochloride (GRK2-IN-1 hydrochloride) CCG258208 (GRK2-IN-1) HCl is a potent and specific inhibitor of GRK2 (G protein-coupled receptor kinase 2) (IC50=30 nM), showing 230-fold activity against GRK5 (IC50=7.09 μM) The selectivity is over 2500-fold for GRK1 (IC50=87.3 μM), PKA and ROCK1.
Cholic acid 7-sulfate-d4 V131650 Cholic acid 7-sulfate-d4 1332881-66-9 Cholic acid 7-sulfate-d4 is a deuterated derivative of 7-sulfocholic acid.
FXR/TGR5 agonist 1 V74029 FXR/TGR5 agonist 1 2677689-72-2 FXR/TGR5 agonist 1 has agonistic effects on FXR and TGR5 and may be utilized to study fatty liver disease.
GPBAR1-IN-3 V75361 GPBAR1-IN-3 2760546-05-0 GPBAR1-IN-3 (Compound 14) is a selective GPBAR1 agonist (EC50=0.17 μM) and CysLT1R antagonist.
GRK2i TFA V76959 GRK2i TFA GRK2i TFA is a GRK2 inhibitory peptide that specifically inhibits Gβγ activation of GRK2.
GRL018-21 V79649 GRL018-21 GRL018-21 is a potent and selective G protein-coupled receptor kinase 5 (GRK5) inhibitor (antagonist) with IC50 of 10 nM.
LIFR/GPBAR1 modulator 1 V116577 LIFR/GPBAR1 modulator 1 LIFR/GPBAR1 modulator 1 is an orally effective potent GPBAR1 agonist (EC50 = 0.2 μM) and LIFR inhibitor (IC50 = 7.9 μM).
LT-188A V139100 LT-188A 2922530-99-0 LT-188A is a potent TGR5 agonist with an EC50 of 23 μM.
Norhyodeoxycholic acid V141564 Norhyodeoxycholic acid 77518-23-1 Norhyodeoxycholic acid is a synthetic bile acid and a derivative of porcine deoxycholic acid (HDCA).
PEN (human) V75360 PEN (human) 597578-70-6 PEN (human) is one of the most abundant hypothalamic neuropeptides derived from ProSAAS proprotein and is the endogenous ligand of GPR83.
PEN (human) TFA V142414 PEN (human) TFA PEN (human) TFA is one of the most abundant neuropeptides in the hypothalamus, derived from the proprotein ProSAAS, and is an endogenous ligand of GPR83.
PEN (rat) V75363 PEN (rat) 569364-13-2 PEN (rat) is one of the most abundant hypothalamic neuropeptides derived from ProSAAS proprotein and is the endogenous ligand of GPR83.
Contact Us